Literature DB >> 19362967

CD27 in defining memory B-cell origins in Waldenström's macroglobulinemia.

Surinder S Sahota1, Gavin Babbage, Nicola J Weston-Bell.   

Abstract

CD27 is a tumor necrosis factor receptor family glycoprotein, identified in seminal studies as an apparently robust marker for normal memory B cells. Somatic hypermutation (SHM) in immunoglobulin variable (V) region genes, however, remains the definitive memory imprint. In Waldenström's macroglobulinemia (WM), SHM defines a predominant mutated (MUT) subset and a minor unmutated subset indicative of naive B-cell origin. In MUT-WM, tumor cells can lack CD27 expression, raising suggestions of unusual memory B-cell origins. We recently identified such normal IgM+D+CD27-ve memory B-cells, with low levels of SHM in VH genes. While these could seed WM, the possibility remains that WM could derive from classical memory B cells that shed CD27. The utility of CD27 expression in defining memory in MUT-WM origins, then, is uncertain, but SHM unequivocally defines memory B-cell derivation in most WM. Patterns of SHM and additional IgH locus events furthermore reveal ongoing intra-tumoral diversification in WM.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362967     DOI: 10.3816/CLM.2009.n.007

Source DB:  PubMed          Journal:  Clin Lymphoma Myeloma        ISSN: 1557-9190


  4 in total

1.  Transcriptome sequencing reveals a profile that corresponds to genomic variants in Waldenström macroglobulinemia.

Authors:  Zachary R Hunter; Lian Xu; Guang Yang; Nicholas Tsakmaklis; Josephine M Vos; Xia Liu; Jie Chen; Robert J Manning; Jiaji G Chen; Philip Brodsky; Christopher J Patterson; Joshua Gustine; Toni Dubeau; Jorge J Castillo; Kenneth C Anderson; Nikhil M Munshi; Steven P Treon
Journal:  Blood       Date:  2016-06-14       Impact factor: 22.113

2.  IgM-MM is predominantly a pre-germinal center disorder and has a distinct genomic and transcriptomic signature from WM.

Authors:  Abdul Hamid Bazarbachi; Hervé Avet-Loiseau; Raphael Szalat; Anil Aktas Samur; Zachary Hunter; Masood Shammas; Jill Corre; Mariateresa Fulciniti; Kenneth C Anderson; Giovanni Parmigiani; Steven P Treon; Mohamad Mohty; Nikhil C Munshi; Mehmet Kemal Samur
Journal:  Blood       Date:  2021-11-18       Impact factor: 22.113

Review 3.  Waldenstrom's macroglobulinemia: Recent advances in biology and therapy.

Authors:  Natalia Neparidze; Madhav V Dhodapkar
Journal:  Clin Adv Hematol Oncol       Date:  2009-10

4.  Clonotypic analysis of immunoglobulin heavy chain sequences in patients with Waldenström's macroglobulinemia: correlation with MYD88 L265P somatic mutation status, clinical features, and outcome.

Authors:  Loizos Petrikkos; Marie-Christine Kyrtsonis; Maria Roumelioti; George Georgiou; Anna Efthymiou; Tatiana Tzenou; Panayiotis Panayiotidis
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.